Inspiremd is based out of Tel Aviv. InspireMD, Inc., a medical device company, engages in the development and commercialization of stent platform technology in Israel. The company provides MGuard, a stent platform that offers embolic protection in stenting procedures by placing a micron mesh sleeve over a stent. It offers its products for use in patients with acute coronary syndromes, primarily acute myocardial infarction and saphenous vein graft coronary interventions. The company���s products include MGuard Coronary that comprises a mesh sleeve wrapped around a bare-metal stent; MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent; and MGuard Coronary with a drug eluting mesh that provides bio-absorbability and uniform drug therapy management. It sells its products through distributors in Europe, Asia, and Latin America.Whalewisdom has at least 108 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2023-05-30. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
INSPIREMD, INC.4 MENORAT HAMAOR ST.
TEL AVIV L3 6744832
Business Phone: (888) 776-6804
SEC SIC CODE:
3841-SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
3841-SURGICAL & MEDICAL INSTRUMENTS & APPARATUS